Trial Profile
Tau PET pattern in corticobasal syndrome patients by using the 18F-AV-1451 positron emission tomography (PET)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2017
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Corticobasal degeneration
- Focus Diagnostic use
- 28 Aug 2017 New trial record
- 16 Aug 2017 Results published in the Neurology
- 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017